Market size, growth to 2033 and clinical trials, side by side.
China is the bigger Home Healthcare market: $29.1 Bn against $6.6 Bn in 2023, about 4.4 times as large.
India grows faster: 10.9% a year, against 9.4%. The gap still grows from $22.5 Bn to $53 Bn by 2033.
Clinical research: 340 active trials in China, 40 in India.
| Measure | ||
|---|---|---|
| Market size, 2023 | $29.1 Bn | $6.6 Bn |
| Market size, 2033 projected | $71.5 Bn | $18.5 Bn |
| Growth a year (CAGR) | 9.4% | 10.9% |
| Money added, 2023–2033 | $42.4 Bn | $11.9 Bn |
| Share of the world market | 8% | 1.8% |
| Size rank of 24 countries | #2 | #12 |
| Market per person, 2023 | $21 | $4.50 |
| Active clinical trials | 340 | 40 |
| Full report | China report | India report |
China India · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
China is the bigger Home Healthcare market: $29.1 Bn against $6.6 Bn in 2023, about 4.4 times as large.
India grows faster: 10.9% a year, against 9.4%. The gap still grows from $22.5 Bn to $53 Bn by 2033.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.